Sickle cell community scrambles to find safe plan after a drug is pulled from the market

On Wednesday, Pfizer announced it was pulling the drug off the market — and doctors have been scrambling ever since to protect their patients from what Habib endured. Everyone was caught between two possibilities: Taking the drug might put patients at risk, but abruptly stopping the drug could put patients at risk, too.